Boston, United States
PostEra, founded in 2019 and headquartered in the United States, is revolutionizing the biotech industry with its slogan, "Medicinal Chemistry powered by Machine Learning." The company is leveraging AI and machine learning through its proprietary platform, Proton, to accelerate drug discovery and development in the fields of biotechnology and pharmaceuticals.
PostEra's internal pipeline is focused on Women’s Health and Fertility, specifically advancing noteworthy clinical candidates such as PERA-5720 and PERA-8103. They have successfully secured significant partnerships, including over $1B in AI collaborations with major pharmaceutical companies like Pfizer and Amgen. Additionally, PostEra leads a pandemic preparedness initiative supported by a substantial NIH grant investment, received on 01 May 2022.
This company stands out in the competitive landscape due to its strategic focus on leveraging AI for scalable medicinal chemistry solutions and its strong collaborative infrastructure.
Vm Discovery Inc